GlassScriptPhysician profile
Betty Anthony
NPI 1568572584
$4,258.25
in general payments reported to CMS, 2019-2025
31 companies · $414 in 2025
The $414 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $1,214 · 2021: $689 · 2022: $360 · 2023: $462 · 2024: $715 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,590.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $762.95 | 2020 | |
| Abbvie INC. | $729.83 | 2019-2023 | Lo Loestrin Fe |
| Amgen INC. | $612.83 | 2020-2025 | Evenity, Prolia, Prolia |
| Mayne Pharma Commercial LLC | $575.32 | 2021-2025 | |
| Astellas Pharma US INC | $267.80 | 2023-2025 | Veozah |
| Lupin INC. | $227.87 | 2019-2021 | |
| Organon LLC | $163.92 | 2021-2024 | Nexplanon |
| Exeltis, USA INC. | $163.46 | 2020-2025 | Slynd |
| Pfizer INC. | $104.99 | 2019-2025 | |
| Agile Therapeutics, INC. | $100.72 | 2021-2022 | |
| Aspira Women'S Health INC | $74.01 | 2020-2022 | |
| Avion Pharmaceuticals | $52.57 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $51.37 | 2021 | |
| Scynexis, INC. | $41.71 | 2022 | |
| Shield Therapeutics INC | $35.82 | 2022-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $30.88 | 2020 | |
| Myovant Sciences INC. | $30.33 | 2021 | |
| Dysis Medical, INC. | $24.38 | 2020 | |
| Heron Therapeutics, INC. | $21.25 | 2023 | Zynrelef |
| Daiichi Sankyo INC. | $19.48 | 2019 | |
| Vertical Pharmaceuticals, LLC | $19.46 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.52 | 2022 | |
| Roche Diagnostics Corporation | $18.23 | 2019 | |
| Ibsa Pharma INC. | $16.18 | 2023 | Tirosint, Licart |
| Exact Sciences Corporation | $16.07 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $15.78 | 2021 | |
| Merck Sharp & Dohme LLC | $15.13 | 2019 | |
| Zyla Life Sciences, INC. | $12.64 | 2020 | |
| Allergan, INC. | $12.59 | 2019 | |
| Coopersurgical, INC. | $12.44 | 2019 | |
| Meditrina | $9.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betty Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.